Literature DB >> 14991823

CYP2D6 polymorphism, pesticide exposure, and Parkinson's disease.

Alexis Elbaz1, Clotilde Levecque, Jacqueline Clavel, Jean-Sébastien Vidal, Florence Richard, Philippe Amouyel, Annick Alpérovitch, Marie-Christine Chartier-Harlin, Christophe Tzourio.   

Abstract

We performed a case-control study of Parkinson's disease (PD) in a population characterized by a high prevalence of pesticide exposure and studied the joint effect of pesticide exposure and CYP2D6. Although they are based on a small group of subjects with the joint exposure, our findings are consistent with a gene-environment interaction disease model according to which (1) pesticides have a modest effect in subjects who are not CYP2D6 poor metabolizers, (2) pesticides' effect is increased in poor metabolizers (approximately twofold), and (3) poor metabolizers are not at increased PD risk in the absence of pesticide exposure.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14991823     DOI: 10.1002/ana.20051

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  50 in total

1.  Cytochrome P450 2D6 enzyme neuroprotects against 1-methyl-4-phenylpyridinium toxicity in SH-SY5Y neuronal cells.

Authors:  Amandeep Mann; Rachel F Tyndale
Journal:  Eur J Neurosci       Date:  2010-03-22       Impact factor: 3.386

Review 2.  Gene-environment interactions in Parkinson's disease: specific evidence in humans and mammalian models.

Authors:  Jason R Cannon; J Timothy Greenamyre
Journal:  Neurobiol Dis       Date:  2012-07-07       Impact factor: 5.996

3.  The neurotoxicology of hard foraging and fat-melts.

Authors:  Caleb E Finch
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-20       Impact factor: 11.205

4.  Brain drug-metabolizing cytochrome P450 enzymes are active in vivo, demonstrated by mechanism-based enzyme inhibition.

Authors:  Sharon Miksys; Rachel F Tyndale
Journal:  Neuropsychopharmacology       Date:  2008-07-30       Impact factor: 7.853

5.  Pooled analysis of iron-related genes in Parkinson's disease: association with transferrin.

Authors:  Shannon L Rhodes; Daniel D Buchanan; Ismaïl Ahmed; Kent D Taylor; Marie-Anne Loriot; Janet S Sinsheimer; Jeff M Bronstein; Alexis Elbaz; George D Mellick; Jerome I Rotter; Beate Ritz
Journal:  Neurobiol Dis       Date:  2013-10-08       Impact factor: 5.996

6.  Polymorphic genes of detoxification and mitochondrial enzymes and risk for progressive supranuclear palsy: a case control study.

Authors:  Lisa F Potts; Alex C Cambon; Owen A Ross; Rosa Rademakers; Dennis W Dickson; Ryan J Uitti; Zbigniew K Wszolek; Shesh N Rai; Matthew J Farrer; David W Hein; Irene Litvan
Journal:  BMC Med Genet       Date:  2012-03-17       Impact factor: 2.103

7.  Occupational exposure in parkinsonian disorders: a 43-year prospective cohort study in men.

Authors:  Adina L Feldman; Anna L V Johansson; Gun Nise; Margaret Gatz; Nancy L Pedersen; Karin Wirdefeldt
Journal:  Parkinsonism Relat Disord       Date:  2011-07-05       Impact factor: 4.891

Review 8.  Cytochrome P450-mediated drug metabolism in the brain.

Authors:  Sharon Miksys; Rachel F Tyndale
Journal:  J Psychiatry Neurosci       Date:  2013-05       Impact factor: 6.186

9.  MDR1 variants and risk of Parkinson disease. Association with pesticide exposure?

Authors:  Katja Zschiedrich; Inke R König; Norbert Brüggemann; Norman Kock; Meike Kasten; Klaus L Leenders; Vladimir Kostić; Peter Vieregge; Andreas Ziegler; Christine Klein; Katja Lohmann
Journal:  J Neurol       Date:  2009-01-29       Impact factor: 4.849

10.  Dopamine transporter genetic variants and pesticides in Parkinson's disease.

Authors:  Beate R Ritz; Angelika D Manthripragada; Sadie Costello; Sarah J Lincoln; Matthew J Farrer; Myles Cockburn; Jeff Bronstein
Journal:  Environ Health Perspect       Date:  2009-02-22       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.